Cargando…
SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: Genomic surveillance in Japan from September 2021 to March 2022
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050183/ https://www.ncbi.nlm.nih.gov/pubmed/35490739 http://dx.doi.org/10.1016/j.jinf.2022.04.040 |
| _version_ | 1784696304604020736 |
|---|---|
| author | Hirotsu, Yosuke Maejima, Makoto Shibusawa, Masahiro Natori, Yume Nagakubo, Yuki Hosaka, Kazuhiro Sueki, Hitomi Mochizuki, Hitoshi Tsutsui, Toshiharu Kakizaki, Yumiko Miyashita, Yoshihiro Omata, Masao |
| author_facet | Hirotsu, Yosuke Maejima, Makoto Shibusawa, Masahiro Natori, Yume Nagakubo, Yuki Hosaka, Kazuhiro Sueki, Hitomi Mochizuki, Hitoshi Tsutsui, Toshiharu Kakizaki, Yumiko Miyashita, Yoshihiro Omata, Masao |
| author_sort | Hirotsu, Yosuke |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9050183 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90501832022-04-29 SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: Genomic surveillance in Japan from September 2021 to March 2022 Hirotsu, Yosuke Maejima, Makoto Shibusawa, Masahiro Natori, Yume Nagakubo, Yuki Hosaka, Kazuhiro Sueki, Hitomi Mochizuki, Hitoshi Tsutsui, Toshiharu Kakizaki, Yumiko Miyashita, Yoshihiro Omata, Masao J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-08 2022-04-29 /pmc/articles/PMC9050183/ /pubmed/35490739 http://dx.doi.org/10.1016/j.jinf.2022.04.040 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Hirotsu, Yosuke Maejima, Makoto Shibusawa, Masahiro Natori, Yume Nagakubo, Yuki Hosaka, Kazuhiro Sueki, Hitomi Mochizuki, Hitoshi Tsutsui, Toshiharu Kakizaki, Yumiko Miyashita, Yoshihiro Omata, Masao SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: Genomic surveillance in Japan from September 2021 to March 2022 |
| title | SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: Genomic surveillance in Japan from September 2021 to March 2022 |
| title_full | SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: Genomic surveillance in Japan from September 2021 to March 2022 |
| title_fullStr | SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: Genomic surveillance in Japan from September 2021 to March 2022 |
| title_full_unstemmed | SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: Genomic surveillance in Japan from September 2021 to March 2022 |
| title_short | SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: Genomic surveillance in Japan from September 2021 to March 2022 |
| title_sort | sars-cov-2 omicron sublineage ba.2 replaces ba.1.1: genomic surveillance in japan from september 2021 to march 2022 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050183/ https://www.ncbi.nlm.nih.gov/pubmed/35490739 http://dx.doi.org/10.1016/j.jinf.2022.04.040 |
| work_keys_str_mv | AT hirotsuyosuke sarscov2omicronsublineageba2replacesba11genomicsurveillanceinjapanfromseptember2021tomarch2022 AT maejimamakoto sarscov2omicronsublineageba2replacesba11genomicsurveillanceinjapanfromseptember2021tomarch2022 AT shibusawamasahiro sarscov2omicronsublineageba2replacesba11genomicsurveillanceinjapanfromseptember2021tomarch2022 AT natoriyume sarscov2omicronsublineageba2replacesba11genomicsurveillanceinjapanfromseptember2021tomarch2022 AT nagakuboyuki sarscov2omicronsublineageba2replacesba11genomicsurveillanceinjapanfromseptember2021tomarch2022 AT hosakakazuhiro sarscov2omicronsublineageba2replacesba11genomicsurveillanceinjapanfromseptember2021tomarch2022 AT suekihitomi sarscov2omicronsublineageba2replacesba11genomicsurveillanceinjapanfromseptember2021tomarch2022 AT mochizukihitoshi sarscov2omicronsublineageba2replacesba11genomicsurveillanceinjapanfromseptember2021tomarch2022 AT tsutsuitoshiharu sarscov2omicronsublineageba2replacesba11genomicsurveillanceinjapanfromseptember2021tomarch2022 AT kakizakiyumiko sarscov2omicronsublineageba2replacesba11genomicsurveillanceinjapanfromseptember2021tomarch2022 AT miyashitayoshihiro sarscov2omicronsublineageba2replacesba11genomicsurveillanceinjapanfromseptember2021tomarch2022 AT omatamasao sarscov2omicronsublineageba2replacesba11genomicsurveillanceinjapanfromseptember2021tomarch2022 |